Predicting initiation and progression of chronic kidney disease: Developing renal risk scores.

[1]  Zhongxin Zhang,et al.  Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[2]  V. Howard,et al.  Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. , 2006, Journal of the American Society of Nephrology : JASN.

[3]  Rury R Holman,et al.  Risk Factors for Renal Dysfunction in Type 2 Diabetes , 2006, Diabetes.

[4]  Carlos Iribarren,et al.  Body Mass Index and Risk for End-Stage Renal Disease , 2006, Annals of Internal Medicine.

[5]  B. Brenner,et al.  Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL. , 2006, Kidney international.

[6]  M. Hughson,et al.  Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. , 2006, Kidney international.

[7]  K. Kalantar-Zadeh,et al.  Association of anemia with outcomes in men with moderate and severe chronic kidney disease. , 2006, Kidney international.

[8]  R. Agarwal,et al.  Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. , 2006, Kidney international.

[9]  B. Eriksen,et al.  The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. , 2006, Kidney international.

[10]  T. Nakagawa,et al.  Hormonal and cytokine effects of uric acid , 2006, Current opinion in nephrology and hypertension.

[11]  B. Brenner,et al.  'Hypertension' and 'microalbuminuria': the bell tolls for thee. , 2006, Kidney international.

[12]  K. Leung,et al.  Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  J. Manson,et al.  Association between body mass index and CKD in apparently healthy men. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  E. Ritz,et al.  Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus. , 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  J. Mclaughlin,et al.  The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[16]  D. Dunger,et al.  The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study. , 2005, Kidney international.

[17]  B. Freedman,et al.  Population-Based Screening for Family History of End-Stage Renal Disease among Incident Dialysis Patients , 2005, American Journal of Nephrology.

[18]  F. Dekker,et al.  Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. , 2005, Journal of the American Society of Nephrology : JASN.

[19]  B. Brenner,et al.  Low birth weight, nephron number, and kidney disease. , 2005, Kidney international. Supplement.

[20]  Carmine Zoccali,et al.  Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach. , 2005, Journal of the American Society of Nephrology : JASN.

[21]  G. Chertow,et al.  Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. , 2005, Journal of the American Society of Nephrology : JASN.

[22]  H. Kramer,et al.  Progression of kidney disease in type 2 diabetes – beyond blood pressure control: an observational study , 2005, BMC nephrology.

[23]  G. Bakris,et al.  The relationship between magnitude of proteinuria reduction and risk of end-stage renal disease: results of the African American study of kidney disease and hypertension. , 2005, Archives of internal medicine.

[24]  C. McCulloch,et al.  Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. , 2005, Archives of internal medicine.

[25]  G. Beck,et al.  The Effect of a Lower Target Blood Pressure on the Progression of Kidney Disease: Long-Term Follow-up of the Modification of Diet in Renal Disease Study , 2005, Annals of Internal Medicine.

[26]  G. Remuzzi,et al.  Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial , 2005, The Lancet.

[27]  E. Lewis,et al.  Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. , 2005, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[28]  Jaime Herrera-Acosta,et al.  Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats. , 2005, Kidney international.

[29]  Amit X Garg,et al.  Classifying kidney problems: can we avoid framing risks as diseases? , 2004, BMJ : British Medical Journal.

[30]  Taku Inoue,et al.  Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. , 2004, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[32]  Zhongxin Zhang,et al.  Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. , 2004, Kidney international.

[33]  K. Siamopoulos,et al.  Treating anemia early in renal failure patients slows the decline of renal function: a randomized controlled trial. , 2004, Kidney international.

[34]  B. Rosner,et al.  Lifetime nonnarcotic analgesic use and decline in renal function in women. , 2004, Archives of internal medicine.

[35]  W. McClellan,et al.  Medicare patients with cardiovascular disease have a high prevalence of chronic kidney disease and a high rate of progression to end-stage renal disease. , 2004, Journal of the American Society of Nephrology : JASN.

[36]  L. Stevens,et al.  The profile of cardiac patients with renal artery stenosis. , 2004, Journal of the American College of Cardiology.

[37]  Ja‐Liang Lin,et al.  Environmental exposure to lead and progression of chronic renal diseases: a four-year prospective longitudinal study. , 2004, Journal of the American Society of Nephrology : JASN.

[38]  L. Forsgren,et al.  Incidence and prevalence , 2004 .

[39]  Daniel Levy,et al.  Predictors of new-onset kidney disease in a community-based population. , 2004, JAMA.

[40]  Jing Chen,et al.  The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults , 2004, Annals of Internal Medicine.

[41]  G. Remuzzi,et al.  Cellular responses to protein overload: key event in renal disease progression , 2004, Current opinion in nephrology and hypertension.

[42]  P. Hindmarsh,et al.  Glomerular and tubular function in glycogen storage disease , 1995, Pediatric Nephrology.

[43]  N. Powe,et al.  Screening for proteinuria in US adults: a cost-effectiveness analysis. , 2003, JAMA.

[44]  G. Wolf.  After all those fat years: renal consequences of obesity. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[45]  D. Sandler,et al.  Lifestyle risk factors and chronic kidney disease. , 2003, Annals of epidemiology.

[46]  Josef Coresh,et al.  Risk factors for chronic kidney disease: a prospective study of 23,534 men and women in Washington County, Maryland. , 2003, Journal of the American Society of Nephrology : JASN.

[47]  C. Schmid,et al.  The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[48]  J. Buring,et al.  Cholesterol and the risk of renal dysfunction in apparently healthy men. , 2003, Journal of the American Society of Nephrology : JASN.

[49]  E. Rimm,et al.  Moderate alcohol intake and renal function decline in women: a prospective study. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[50]  Neil R. Powe,et al.  Lifestyle Factors, Obesity and the Risk of Chronic Kidney Disease , 2003, Epidemiology.

[51]  W. McClellan,et al.  Risk factors for progressive chronic kidney disease. , 2003, Journal of the American Society of Nephrology : JASN.

[52]  M. Hughson,et al.  Glomerular number and size in autopsy kidneys: the relationship to birth weight. , 2003, Kidney international.

[53]  G. Remuzzi,et al.  Retarding progression of chronic renal disease: the neglected issue of residual proteinuria. , 2003, Kidney international.

[54]  F. Sacks,et al.  Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. , 2003, Journal of the American Society of Nephrology : JASN.

[55]  T. Weinstein,et al.  The effects of weight loss on renal function in patients with severe obesity. , 2003, Journal of the American Society of Nephrology : JASN.

[56]  B. Dimitrov,et al.  Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual level. , 2003, Kidney international.

[57]  G. Navis,et al.  A central body fat distribution is related to renal function impairment, even in lean subjects. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[58]  D. Spiegelman,et al.  The Impact of Protein Intake on Renal Function Decline in Women with Normal Renal Function or Mild Renal Insufficiency , 2003, Annals of Internal Medicine.

[59]  Jackson T. Wright,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease. Results from the AASK trial , 2003 .

[60]  M. Carnethon,et al.  Association of dietary protein intake and microalbuminuria in healthy adults: Third National Health and Nutrition Examination Survey. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[61]  J. Coresh,et al.  Blood lead and chronic kidney disease in the general United States population: results from NHANES III. , 2003, Kidney international.

[62]  L. Bostad,et al.  Clinical prognostic factors in biopsy-proven benign nephrosclerosis. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[63]  J. Scheinman.  Sickle cell disease and the kidney. , 2003, Seminars in nephrology.

[64]  C. Jurkovitz,et al.  Family members of patients treated for ESRD have high rates of undetected kidney disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[65]  Tom Greene,et al.  Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. , 2002, JAMA.

[66]  T. Nakagawa,et al.  Mild hyperuricemia induces glomerular hypertension in normal rats. , 2002, American journal of physiology. Renal physiology.

[67]  E. Ritz,et al.  The renal risks of smoking: an update , 2002, Current opinion in nephrology and hypertension.

[68]  N. Powe,et al.  Excess risk of chronic kidney disease among African-American versus white subjects in the United States: a population-based study of potential explanatory factors. , 2002, Journal of the American Society of Nephrology : JASN.

[69]  B. Kiberd,et al.  Cumulative risk for developing end-stage renal disease in the US population. , 2002, Journal of the American Society of Nephrology : JASN.

[70]  A. Garg,et al.  Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). , 2002, Journal of the American Society of Nephrology : JASN.

[71]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[72]  J Singer,et al.  Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[73]  K. Iseki,et al.  Significance of hyperuricemia on the early detection of renal failure in a cohort of screened subjects. , 2001, Hypertension research : official journal of the Japanese Society of Hypertension.

[74]  B. Brenner,et al.  Pathogenesis of diabetic nephropathy: focus on transforming growth factor-β and connective tissue growth factor , 2001, Current opinion in nephrology and hypertension.

[75]  C. Schmid,et al.  Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease. , 2001, Kidney international.

[76]  P. Whelton,et al.  Recreational drug use: a neglected risk factor for end-stage renal disease. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[77]  V. D’Agati,et al.  Obesity-related glomerulopathy: an emerging epidemic. , 2001, Kidney international.

[78]  F. Berthoux,et al.  Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[79]  K. Godfrey,et al.  Fetal programming and adult health , 2001, Public Health Nutrition.

[80]  Hideho Gomi,et al.  Serum Uric Acid and Renal Prognosis in Patients with IgA Nephropathy , 2001, Nephron.

[81]  B. Kasiske,et al.  Effect of lipid reduction on the progression of renal disease: a meta-analysis. , 2001, Kidney international.

[82]  M. Laville,et al.  Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[83]  I. Mühlhauser,et al.  Predictors of mortality and end‐stage diabetic complications in patients with Type 1 diabetes mellitus on intensified insulin therapy , 2000, Diabetic medicine : a journal of the British Diabetic Association.

[84]  B. Giraudeau,et al.  Effects of current smoking and smoking discontinuation on renal function and proteinuria in the general population. , 2000, Kidney international.

[85]  R. Mañalich,et al.  Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. , 2000, Kidney international.

[86]  D. Bates,et al.  Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[87]  J. Coresh,et al.  Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. , 2000, Kidney international.

[88]  D. Hémon,et al.  Age, blood pressure and smoking effects on chronic renal failure in primary glomerular nephropathies. , 2000, Kidney international.

[89]  D. Lackland,et al.  Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States. , 2000, Archives of internal medicine.

[90]  G. Burke,et al.  Tobacco, hypertension, and vascular disease: risk factors for renal functional decline in an older population. , 2000, Kidney international.

[91]  D. Wesson,et al.  Cigarette smoking is associated with augmented progression of renal insufficiency in severe essential hypertension. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[92]  K. Ataga,et al.  Renal abnormalities in sickle cell disease , 2000, American journal of hematology.

[93]  B. Brenner,et al.  Multi-hit nature of chronic renal disease. , 2000, Current opinion in nephrology and hypertension.

[94]  A. Morris,et al.  Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. , 2000, Hypertension.

[95]  S. Silbiger,et al.  Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. , 2000, Journal of the American Society of Nephrology : JASN.

[96]  J. Mustonen,et al.  Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[97]  P. Whelton,et al.  Risk of end-stage renal disease associated with alcohol consumption. , 1999, American journal of epidemiology.

[98]  J. Mathews,et al.  A new dimension to the Barker hypothesis: low birthweight and susceptibility to renal disease. , 1999, Kidney international.

[99]  L. Chambless,et al.  A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs whites with diabetes: the Atherosclerosis Risk in Communities study. , 1999, Archives of internal medicine.

[100]  H. Morgenstern,et al.  Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus. , 1998, American journal of epidemiology.

[101]  R. Holman,et al.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .

[102]  W. Chow,et al.  Analgesic use and chronic renal failure: a critical review of the epidemiologic literature. , 1998, Kidney international.

[103]  C. Wanner,et al.  Smoking as a risk factor for end-stage renal failure in men with primary renal disease. , 1998, Kidney international.

[104]  P. Whelton,et al.  Familial aggregation of renal disease in a population-based case-control study. , 1998, Journal of the American Society of Nephrology : JASN.

[105]  J. Bansard,et al.  [Outcome of renal function in 114 patients who underwent uninephrectomy for renal cancer]. , 1998, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[106]  T A Louis,et al.  A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[107]  P. Snelling,et al.  An epidemic of renal failure among Australian Aboriginals , 1998, The Medical journal of Australia.

[108]  H. Wedel,et al.  Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[109]  G. Beck,et al.  Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. , 1997, Kidney international.

[110]  O. B. O. T. I. Group,et al.  Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM , 1997, Diabetologia.

[111]  P. Whelton,et al.  End-stage renal disease in African-American and white men. 16-year MRFIT findings. , 1997, JAMA.

[112]  O. Tomonaga,et al.  Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients , 1997, Diabetologia.

[113]  Y. Kawaguchi,et al.  Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. , 1997, Nephron.

[114]  P. Roderick,et al.  The need and demand for renal replacement therapy in ethnic minorities in England. , 1996, Journal of epidemiology and community health.

[115]  A. Levey,et al.  Effects of dietary protein restriction on the progression of advanced renal disease in the Modification of Diet in Renal Disease Study. , 1996, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[116]  Ping Wang,et al.  The Effect of Dietary Protein Restriction on the Progression of Diabetic and Nondiabetic Renal Diseases , 1996, Annals of Internal Medicine.

[117]  K. Iseki,et al.  Risk of developing end-stage renal disease in a cohort of mass screening. , 1996, Kidney international.

[118]  P. Whelton,et al.  Blood pressure and end-stage renal disease in men. , 1996, The New England journal of medicine.

[119]  T. Greene,et al.  Blood Pressure Control, Proteinuria, and the Progression of Renal Disease , 1995, Annals of Internal Medicine.

[120]  V. Manninen,et al.  Effects of hypertension and dyslipidemia on the decline in renal function. , 1995, Hypertension.

[121]  T. Louis,et al.  Long-term effects of reduced renal mass in humans. , 1995, Kidney international.

[122]  B. Freedman,et al.  Familial risk, age at onset, and cause of end-stage renal disease in white Americans. , 1995, Journal of the American Society of Nephrology : JASN.

[123]  S. K. Park,et al.  Renal Function and Hemodynamic Study in Obese Zucker Rats , 1995, The Korean journal of internal medicine.

[124]  T V Perneger,et al.  Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. , 1994, The New England journal of medicine.

[125]  C. Baylis,et al.  Age-dependent glomerular damage in the rat. Dissociation between glomerular injury and both glomerular hypertension and hypertrophy. Male gender as a primary risk factor. , 1994, The Journal of clinical investigation.

[126]  G. Beck,et al.  The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease , 1994 .

[127]  S. Genuth,et al.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.

[128]  Martin G. Larson,et al.  Long-Term Epidemiologic Prediction of Coronary Disease , 1993 .

[129]  S. Studenski,et al.  Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking. , 1992, Archives of internal medicine.

[130]  B. Kasiske,et al.  Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. , 1992, The American journal of physiology.

[131]  A. Novick,et al.  Long-term follow-up after partial removal of a solitary kidney. , 1991, The New England journal of medicine.

[132]  C. Weinberg,et al.  Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. , 1991, Annals of internal medicine.

[133]  C. Weinberg,et al.  Analgesic use and chronic renal disease. , 1989, The New England journal of medicine.

[134]  M. Blaufox,et al.  Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. , 1989, Hypertension.

[135]  S. Klahr.  The modification of diet in renal disease study. , 1989, The New England journal of medicine.

[136]  G. Remuzzi,et al.  Age-related nephropathy and proteinuria in rats with intact kidneys exposed to diets with different protein content. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[137]  R. Hoeldtke,et al.  Protein-induced glomerular hyperfiltration: role of hormonal factors. , 1988, Kidney international.

[138]  S. Haffner,et al.  Excess incidence of treatment of end-stage renal disease in Mexican Americans. , 1988, American journal of epidemiology.

[139]  M. Hughson,et al.  Epidemic renal disease of unknown etiology in the Zuni Indians. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[140]  J. Bosch,et al.  Renal hemodynamic changes in humans. Response to protein loading in normal and diseased kidneys. , 1986, The American journal of medicine.

[141]  B. Brenner,et al.  Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension. , 1986, The Journal of clinical investigation.

[142]  C. Ponticelli,et al.  Prognostic indicators in idiopathic IgA mesangial nephropathy. , 1986, The Quarterly journal of medicine.

[143]  B. Brenner,et al.  Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[144]  N W Shock,et al.  Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.

[145]  V. Hawthorne,et al.  End-Stage Renal Disease in Michigan , 1985 .

[146]  B. Brenner,et al.  Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. , 1981, The American journal of physiology.

[147]  M. Steffes,et al.  Diabetic Glomerulopathy Following Unilateral Nephrectomy in the Rat , 1978, Diabetes.